Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of CMV-TCR-T Cells in the Treatment of Refractory CMV Viremia After HSCT

NCT05089838 is registered in ClinicalTrials.gov with Xiao-Jun Huang as lead sponsor.

NCT NCT05089838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05089838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of CMV-TCR-T Cells in the Treatment of Refractory CMV Viremia After HSCT
Lead sponsor
Xiao-Jun Huang
Phase
Phase 1
Overall status
Unknown status
Start date
January 6, 2021
Completion date
October 31, 2023
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic hematopoietic stem cell transplantation, cmv infection